RA Capital Management's Biopharma Portfolio

cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities of therapeutic solutions.

Stipple Bio is a biotechnology company that offers cellular profiling and target discovery with epitope resolution.

GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.

Indapta Therapeutics is a privately held biotechnology company.

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

Mariana Oncology is a biotechnology research industry.

ExcepGen is solving fundamental underlying problems in drug discovery to create a new generation of therapeutics.

Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.

Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.

Zura Bio is a clinical-stage, multi-asset biotechnology company.

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.

Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.